MedPath

Comparison of predictive performance between modified Marsh propofol model and Schnider propofol model in underweight patients

Not Applicable
Completed
Conditions
Not Applicable
Registration Number
KCT0001502
Lead Sponsor
Asan Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

1. body mass index (BMI) < 18.5 (kg/m2)
2. Hemoglobin > 9 (mg/dl)
3. Patients undergoing elective surgery under general anesthesia

Exclusion Criteria

1. Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive urine pregnancy test
2. Patients with known hypersensitivity to propofol or to any of the excipients
3. Clinically significant impairment of cardiovascular, respiratory and renal function
4. Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
predictive perfomrance (bias, inaccuracy, wooble divegence)
Secondary Outcome Measures
NameTimeMethod
adverse events
© Copyright 2025. All Rights Reserved by MedPath